Pharmaceutical grade chondroitin sulfate has proved efficacy in the treatment and delay of knee osteoarthritis, according to the latest published evidence on osteoarthritis treatment has been presented at a symposium organized by Bioiberica and IBSA at the Annual European Congress of Rheumatology, being held in Madrid, Spain. A new clinical trial, carried out by IBSA and called CONCEPT(ChONdroitin vs CElecoxib vs Placebo Trial), shows that pharmaceutical grade chondroitin sulfate is as effectiv...
